Dan Felitsky

Dan Felitsky is an accomplished executive in the biotechnology sector, currently serving as President and Chief Scientific Officer at Sfida Ventures, LLC since January 2024. Prior to this role, Dan held the position of Vice President of Immuno-Oncology at TigaTx from January 2022 to December 2023. Dan's extensive experience includes senior leadership roles at Pyxis Oncology, where responsibilities included Senior Director of Discovery Research, Director of Discovery Research, and Interim Head of Protein Sciences. At Jounce Therapeutics, Dan contributed as Principal Scientist and Senior Scientist in Translational Sciences. Dan's career began with a focus on research at GSK and Scripps Research, culminating in a Ph.D. in Biochemistry from the University of Wisconsin-Madison and a Bachelor of Science in Cell and Molecular Biology from Penn State University.